Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001689375-24-000041)

Filing Details

Accession Number:: 0001689375-24-000041
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-07-16 16:43:46
Reporting Period:: 2024-07-12

Accepted Time:: 2024-07-16 16:43:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1689375	Entrada Therapeutics Inc.	TRDA	Pharmaceutical Preparations (2834)	813983399

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1873394	Natarajan Sethuraman	C/O Entrada Therapeutics, Inc. One Design Center Place, Suite 17-500 Boston MA 02210	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-07-12	600	$18.00	189,452	No	4	S	Direct
Common Stock	Disposition	2024-07-15	638	$18.00	188,814	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2023.